We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-10.24%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$903M
AUM Growth
-$116M
Cap. Flow
-$11.6M
Cap. Flow %
-1.29%
Top 10 Hldgs %
46.73%
Holding
67
New
11
Increased
23
Reduced
18
Closed
12

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$29.6M
2
BIIB icon
Biogen
BIIB
+$25.1M
3
COLL icon
Collegium Pharmaceutical
COLL
+$23.2M
4
AET
Aetna Inc
AET
+$21.8M
5
NUVA
NuVasive, Inc.
NUVA
+$20.5M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$45M
2
GILD icon
Gilead Sciences
GILD
+$41.5M
3
ALGN icon
Align Technology
ALGN
+$22.7M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.9M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 90.27%
2 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$315B
$57.3M 6.35%
1,020,576
+50,998
+5% +$2.98M
PFE icon
2
Pfizer
PFE
$143B
$57.3M 6.35%
1,859,618
+74,451
+4% +$2.27M
LLY icon
3
Eli Lilly
LLY
$1.05T
$53.6M 5.94%
729,117
+121,690
+20% +$9.06M
CELG
4
DELISTED
Celgene Corp
CELG
$50.2M 5.56%
433,981
-48,137
-10% -$5.36M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
$40.8M 4.52%
492,100
+80,783
+20% +$6.95M
ACAD icon
6
Acadia Pharmaceuticals
ACAD
$4.38B
$33.9M 3.76%
1,176,543
+1,120,646
+2,005% +$29.6M
NUVA
7
DELISTED
NuVasive, Inc.
NUVA
$33.6M 3.72%
498,689
+318,729
+177% +$20.5M
COLL icon
8
Collegium Pharmaceutical
COLL
$1.17B
$32.8M 3.63%
2,104,756
+1,398,911
+198% +$23.2M
PTLA
9
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$31.9M 3.53%
1,419,404
+196
+0% +$3.83K
DXCM icon
10
DexCom
DXCM
$29.6B
$30.4M 3.37%
2,039,344
+753,336
+59% +$13.3M
ACHC icon
11
Acadia Healthcare
ACHC
$3.17B
$29.3M 3.25%
886,405
+309,636
+54% +$12M
NBIX icon
12
Neurocrine Biosciences
NBIX
$17.2B
$29M 3.21%
748,988
-53,991
-7% -$2.44M
CI icon
13
Cigna
CI
$74.5B
$28.3M 3.14%
212,424
-2,656
-1% -$348K
ABMD
14
DELISTED
Abiomed Inc
ABMD
$28.3M 3.14%
251,416
-2,329
-0.9% -$270K
SHPG
15
DELISTED
Shire pic
SHPG
$26.9M 2.99%
158,158
-7,935
-5% -$1.41M
ISRG icon
16
Intuitive Surgical
ISRG
$122B
$26.9M 2.98%
381,744
+126,918
+50% +$9.33M
TDOC icon
17
Teladoc Health
TDOC
$1.7B
$25.9M 2.87%
1,569,878
+30,260
+2% +$514K
FOLD
18
DELISTED
Amicus Therapeutics
FOLD
$25.3M 2.81%
5,100,198
+905,746
+22% +$6.27M
BIIB icon
19
Biogen
BIIB
$30.4B
$24.1M 2.67%
+84,841
New +$25.1M
NXTM
20
DELISTED
NxStage Medical Inc.
NXTM
$23.4M 2.59%
891,313
-308,556
-26% -$7.63M
AET
21
DELISTED
Aetna Inc
AET
$22.6M 2.5%
+182,185
New +$21.8M
KITE
22
DELISTED
Kite Pharma, Inc.
KITE
$16.7M 1.85%
372,223
+255,897
+220% +$12.6M
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
$16.3M 1.8%
1,125,801
+94,352
+9% +$1.66M
ARAY icon
24
Accuray
ARAY
$30.8M
$14.1M 1.57%
3,072,536
+1,217,911
+66% +$6.32M
ALDR
25
DELISTED
Alder Biopharmaceuticals
ALDR
$13.9M 1.54%
669,351
+132,230
+25% +$3.44M
1
2 3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sectoral Asset Management held 67 positions worth $903M, down 11% from $1.02B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management's Q4 2016 filing shows 11 new, 23 increased, 18 reduced and 12 closed positions. Its largest new stake was Biogen: 84,841 shares worth $24.1M. The largest sale was Medtronic, an estimated $45M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 94% a quarter earlier, followed by Financials.

  • Sectoral Asset Management's largest Q4 2016 buy was Biogen: 84,841 shares worth $24.1M.
  • Sectoral Asset Management added most to Acadia Pharmaceuticals in Q4 2016, an estimated $29.6M increase.
  • Sectoral Asset Management's biggest Q4 2016 reduction was Incyte, cutting an estimated $18.5M.
  • Sectoral Asset Management fully exited Medtronic in Q4 2016, selling an estimated $45M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $903M portfolio in Q4 2016.
  • Sectoral Asset Management opened 11 new positions and closed 12 in Q4 2016.
  • Sectoral Asset Management's portfolio value fell 11% quarter-over-quarter to $903M.

Based on Sectoral Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.